Skip Navigation U.S. Department of Health and Human Services
Agency for Healthcare Research Quality
Archive print banner

AHRQ News and Notes

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

AHRQ releases reports on attention-deficit/hyperactivity disorder

The Agency for Healthcare Research and Quality has released two new research reports—Diagnosis of Attention-Deficit/Hyperactivity Disorder produced by AHRQ contractor Technical Resources International, Inc. (TRI), Rockville, MD, and Treatment of Attention-Deficit/Hyperactivity Disorder produced by McMaster University, Ontario, Canada. McMaster University is 1 of 12 AHRQ Evidence-based Practice Centers (EPCs).

The diagnosis report addresses ADHD prevalence in the general population and in pediatric clinic settings. It also examines the accuracy of both ADHD-specific and general behavioral rating scales as tools to identify children with ADHD, and it reviews evidence on the value of other medical screening tests in children with possible ADHD. The treatment report discusses direct comparisons of pharmacologic treatments and compares pharmacologic and nonpharmacologic interventions.

Taken together, the two reports represent comprehensive, systematic reviews of the existing scientific evidence on ADHD, emphasizing the implications for clinical practice and the opportunities for future research to fill knowledge gaps.

For the diagnosis report, the American Academy of Pediatrics was a partner with AHRQ and TRI. For the treatment report, the McMaster EPC also worked with the American Academy of Pediatrics.

Summaries of the two reports—Technical Review No. 3, Diagnosis of Attention-Deficit/Hyperactivity Disorder (AHRQ Publication No. 99-0050) and Evidence Report/Technology Assessment No. 11, Treatment of Attention-Deficit/Hyperactivity Disorder (AHRQ Publication No. 99-EO18) are available online. Print copies of the summaries are available from the AHRQ Clearinghouse.

Copies of the full report on diagnosis of ADHD (AHRQ Publication No. 99-0050) also are available from the AHRQ Clearinghouse. Full-text copies of the treatment report (AHRQ Publication No. 99-E018) will be available in the near future.

Editor's Note: The National Institute of Mental Health published findings from its ADHD clinical trial in the December 1999 issue of the Archives of General Psychiatry 56, pp. 1073-1086 and 1088-1096.

Return to Contents
Proceed to Next Article

The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care